Maternal and perinatal outcome of temporizing management in 254 consecutive patients with severe pre-eclampsia remote from term

被引:74
作者
Visser, W
Wallenburg, HCS
机构
[1] Erasmus University School of Medicine and Health Sciences, Department of Obstetrics and Gynecology, 3000 DR Rotterdam, Room EE 2283
来源
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY | 1995年 / 63卷 / 02期
关键词
pre-eclampsia; HELLP; temporizing management; perinatal outcome Hemodynamics;
D O I
10.1016/0301-2115(95)02260-0
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To assess maternal and perinatal outcomes of expectant management with plasma volume expansion and pharmacologic vasodilatation in patients with severe pre-eclampsia remote from term. Study design: All women with severe pre-eclampsia between 20 and 32 weeks' gestation, not in labor and with a live, single fetus admitted to the University Hospital Rotterdam from 1985 to 1993 were managed with the intention to prolong gestation. Treatment consisted of correction of the maternal circulation with vasodilatation by means of dihydralazine and plasma volume expansion under central hemodynamic monitoring. Primary end-points of the study were prolongation of gestation, maternal antepartum and postpartum complications, and fetal and neonatal outcome. Results: Two-hundred fifty-four patients were included. The median prolongation of pregnancy was 14 (range 0-62) days. Hemodynamic treatment was associated with marked objective and subjective improvement in maternal condition. Complications of central hemodynamic monitoring were not observed. Perinatal mortality was 20.5%. Conclusion: Expectant management with plasma volume expansion and pharmacologic vasodilatation under central hemodynamic monitoring of the maternal circulation may delay delivery and enhance fetal maturity and does not appear to be associated with an increased risk of maternal morbidity and mortality.
引用
收藏
页码:147 / 154
页数:8
相关论文
共 33 条
[1]  
CROWLEY P, 1989, EFFECTIVE CARE PREGN, V1, P746
[2]   ANTENATAL CORTICOSTEROID-THERAPY - A METAANALYSIS OF THE RANDOMIZED TRIALS, 1972 TO 1994 [J].
CROWLEY, PA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 173 (01) :322-335
[3]  
HANKINS GDV, 1987, CRITICAL CARE OBSTET, P192
[4]  
HJERTBERG R, 1991, ACTA OBSTET GYNECOL, V71, P439
[5]  
Howie RN, 1977, PRE TERM LAB P 5 STU, p:281
[6]  
KARSDORP VHM, 1992, OBSTET GYNECOL, V80, P679
[7]  
KLOOSTERMAN GJ, 1970, INT J GYNECOL OBSTET, V8, P895, DOI DOI 10.1002/J.1879-3479.1970.TB00313.X
[8]   CARDIOGENIC PULMONARY-EDEMA - PRESENTATION OF PREECLAMPSIA EXACERBATED BY PROSTAGLANDIN ABORTIFACIENTS [J].
LEVY, DM ;
HINSHAW, K ;
KNOX, FM ;
CAMPBELL, DM ;
SUTHERLAND, HW .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1994, 101 (03) :263-265
[9]   HYPERTENSION IN PREGNANCY [J].
LINDHEIMER, MD ;
KATZ, AI .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (11) :675-680
[10]   FETAL GROWTH-RETARDATION AND PRE-ECLAMPSIA [J].
LONG, PA ;
ABELL, DA ;
BEISCHER, NA .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1980, 87 (01) :13-18